Diagnostic Code 6824 · 38 CFR §4.97
Aspergillosis is a lung condition caused by Aspergillus mold, which is found worldwide in soil, decaying vegetation, and building materials. Veterans may develop pulmonary aspergillosis from inhaling spores in moldy barracks, field conditions, or during construction/demolition activities. Forms include allergic bronchopulmonary aspergillosis (ABPA), aspergilloma (fungal ball), and invasive aspergillosis. The VA rates this based on residual lung impairment.
| Rating | Criteria |
|---|---|
| 0% | Infection cleared with no residual impairment demonstrated on PFTs or imaging. |
| 30% | Chronic aspergillosis with mild to moderate PFT impairment. May have a stable aspergilloma requiring monitoring. |
| 50% | Significant pulmonary impairment from chronic or allergic aspergillosis. Requires ongoing antifungal treatment or shows progressive cavitary disease. |
| 100% | Invasive or widely disseminated aspergillosis causing severe respiratory failure or requiring continuous treatment with significant systemic effects. |
Positive Aspergillus serology, cultures, or biopsy results. Chest imaging showing aspergilloma, cavities, or infiltrates. Current PFTs. Records of antifungal treatment. Documentation of exposure circumstances during service.
All forms can potentially be service-connected if you can demonstrate exposure during service. ABPA (allergic form) is most common and often develops in veterans with pre-existing asthma. Aspergilloma can form in lung cavities from prior TB or other lung damage.
Surgical decisions are medical, not rating-related. However, if you have surgery, the VA should rate your post-surgical residuals. Document your condition both before and after any procedure.